MediciNova, a company based in the United States, has appointed Yuichi Iwaki as President and CEO, with David H. Crean serving as Chief Business Officer.
4 reports, 1 independent
Updated Thu 00:00
No new developments lately
- Reports
- 4
- Developments
- 3
- Repetition
- 25%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
MediciNova, a company based in the United States, has appointed Yuichi Iwaki as President and CEO, with David H. Crean serving as Chief Business Officer.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.MediciNova appoints Yuichi Iwaki as President and CEO, with David H. Crean as Chief Business Officer.1 source
MediciNova achieved enrollment in the COMBAT-ALS clinical trial for ALS treatment with MN-166.1 source
MediciNova signed SEPA with Yorkville Advisors.1 source
Keep exploring
The entities involved
-
MediciNova (United States)
company in La Jolla, United States
Nothing else this week.
Coverage
Newest first; wire copies grouped- GlobeNewswireMediciNova to Present at the H.C. Wainwright 27th Annual Global Investment Conference LA JOLLA, Calif., Sept. 03, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the
- GlobeNewswireMediciNova Achieves Enrollment in COMBAT-ALS Clinical Trial LA JOLLA, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDA
- GlobeNewswireMediciNova Announces Signing of a Standby Equity Purchase Agreement for up to $30 Million LA JOLLA, Calif., July 31, 2025 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on t